1. Sanofi weighing options for consumer healthcare unit — Hologic selling medical aesthetics unit for one-tenth of purchase price — Bristol-Myers completes Celgene acquisition — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Pacira Contract

Discussion in 'Innovex' started by Anonymous, Dec 5, 2011 at 11:12 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    predictions on the future of this steaming malignancy of a company?
     
  2. Anonymous

    Anonymous Guest

    Have you checked the stock lately?
     
  3. Anonymous

    Anonymous Guest

    it should be 15. stack et al dont care they are just trying to gun the stock by ANY means possible to extract their money via options and then sell it............the product is too expensive and has limited utility to replace existing options as a pain med --the profitability is nil unless they get nerve block. and even then --not sure how many people want a 3 day nerve block............
     
  4. Anonymous

    Anonymous Guest

    Like the new deal stack worked out. 24 months comp whether he is fired or leaves on his own. Lump sum. instantly vested.
     
  5. Anonymous

    Anonymous Guest

    We have been had!! Time to bolt!! It's over..he has traded only for himself..to hell with those in the field!
     
  6. Anonymous

    Anonymous Guest

    AND, the Andy Dick of RD's lost another rep. Within days!!!!!
     
  7. Anonymous

    Anonymous Guest

    Who is the manager???? Is that curt again????
     
  8. Anonymous

    Anonymous Guest

    I do not think it matters who the manager is at this company... None are to be bragged upon. Lots of reps leaving
     
  9. Anonymous

    Anonymous Guest

    the managers have no power; if they say what they think or dare to say anything that contradicts stack they are persona non grata anyway. the managers have no say over who stays and goes. the fact is that overall sales are relatively poor with the exception of a small group of territories.
     
  10. Anonymous

    Anonymous Guest

    any guess why a handful of territories or one in particular is doing well. any conflict of interest maybe
     
  11. Anonymous

    Anonymous Guest

    Connections, relationships and luck-- Wait until the DUE's come around--It may get ugly for the territories that are doing well.
     
  12. Anonymous

    Anonymous Guest

    how about in the north north east in particular. all those sales in one place. great job. makes the rest of reps look weak. best practices?
     
  13. Anonymous

    Anonymous Guest

    Where are you talking about--- thought Texas was the biggest sales contributor! You need to check your numbers!!
     
  14. Anonymous

    Anonymous Guest

    this makes no sense: as is is usually the case in pharma, the NE has been slow from the beginning.
     
  15. Anonymous

    Anonymous Guest

    Please elaborate re off label.
    What do you mean, "get in a few joints"
     
  16. Anonymous

    Anonymous Guest

    correct sales in northeast are slow except in a very very few individual accts. why cant they leverage that to other accts or northeast territories. Should be doing more to promote that success. the rest of us ar getting killed. how some of these northeast hospitals using it so freely
     
  17. Anonymous

    Anonymous Guest

    How are you getting "killed"?
     
  18. Anonymous

    Anonymous Guest

    bonus.
     
  19. Anonymous

    Anonymous Guest

    this new "bonus plan" sux big ones.
     
  20. Anonymous

    Anonymous Guest

    we are getting raped by pacira,,,the new ortho sales force will cut are money potential big time,,,,lean over everyone the big one is going to be put up the poop shoot.

    and its going to hurt!